| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,191 | 9,773 | 9,704 | 10,233 | | Cost of Revenue | 2,492 | 2,804 | 2,843 | 3,092 | | | Gross Profit |
-
| 6,969 | 6,861 | 7,141 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,418 | 5,508 | 4,993 | 4,846 | | Non Recurring | (998) | 998 |
-
|
-
| | Others | 1,995 | 6,550 | 960 | 1,225 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (6,086) | 908 | 1,070 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (716) | (6,086) | 908 | 1,070 | | Interest Expense | 460 | 501 | 530 | 587 | | Income Before Tax | (1,176) | (6,587) | 377 | 483 | | Income Tax Expense | (456) | (2,491) | (33) | 0 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (721) | (4,095) | 410 | 483 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (721) | (4,095) | 410 | 483 | | Preferred Stock And Other Adjustments | (2) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($722) | ($4,095) | $410 | $483 |
|
0.49% Nasdaq 
Income Statement
